Evidence map›Paper›PMID 42384716›Full record

ArticlePLOS digital health2026

Time-series prediction of adverse birth outcomes in the U.S. using multilayer perceptron neural networks.

Bayuh Asmamaw Hailu

Abstract read
In one paragraph

Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Bayuh Asmamaw HailuMonitoring and evaluation, Wollo University, Dessie, Ethiopia.ORCID https://orcid.org/0000-0002-7810-2774

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adverse birth outcomes (ABOs), including preterm birth, low birth weight, low Apgar scores, and neonatal mortality, remain major public health challenges in the United States and disproportionately affect racial, socioeconomic, and demographic subgroups. A time-series multilayer perceptron (MLP) neural network was developed to predict ABOs and identify populations with elevated risk using U.S. Vital Statistics Natality Birth Data from 2009 to 2023, covering 57.9 million births. Unlike standard methods such as ARIMA, the MLP model captures nonlinear relationships among predictors and learns seasonal patterns directly from the data. Key predictors included maternal age, body mass index, adequacy of prenatal care, education, race/ethnicity, and short interpregnancy intervals. Monthly aggregated ABO rates were modeled using data from January 2009 to December 2022 (168 monthly observations), while data from 2023 (12 monthly observations) were reserved as an independent holdout test set. Predictive performance on the holdout set was assessed using root mean square error (RMSE = 0.181), and forecasts were projected through 2030. Between 2009 and 2023, ABO prevalence increased from 14.9% to 15.5%, with Black and American Indian/Alaska Native mothers consistently exhibiting the highest rates. Pregnancy-related medical conditions, advanced maternal age, underweight status, low educational attainment, and short birth intervals were among the variables most strongly associated with model predictions. Projections suggest continued increases in ABO risk among underweight mothers and American Indian/Alaska Native populations. Performance was lower for smaller or structurally disadvantaged subgroups, highlighting challenges in predicting outcomes for high-risk populations. These findings demonstrate that time-series MLP models can support forecasting of adverse birth outcomes and help identify groups experiencing elevated risk. Predictive models may support public health surveillance, maternal health planning, and resource allocation, although forecasts should be interpreted cautiously and are not intended for individual-level clinical decision-making.

Identifiers

PMID42384716
PMCPMC13322551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.